Phase 3 End-stage Kidney Disease Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Phase 3
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Kidney DysfunctionEnd-stage Kidney DiseasePeritoneal Dialysis Complication+2 more
University Health Network, Toronto20 enrolled1 locationNCT05715814
Recruiting
Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
End Stage Renal DiseaseEnd-stage Kidney Disease
VA Office of Research and Development2,540 enrolled8 locationsNCT05931276
Completed
Phase 3
The Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
end-stage kidney disease
haemodialysis
peritoneal dialysis
Australasian Kidney Trials Network- University of Queensland150 enrolled10 locationsACTRN12609000174280